Quantifying the 'hidden' lactose in drugs used for the treatment of gastrointestinal conditions

被引:48
作者
Eadala, P. [1 ]
Waud, J. P. [2 ]
Matthews, S. B. [2 ]
Green, J. T. [1 ]
Campbell, A. K. [3 ]
机构
[1] Llandough Hosp, Dept Gastroenterol, Cardiff CF64 2XX, S Glam, Wales
[2] Llandough Hosp, Dept Med Biochem, Cardiff CF64 2XX, S Glam, Wales
[3] Cardiff Univ, Dept Med Biochem & Immunol, Cardiff, S Glam, Wales
关键词
IRRITABLE-BOWEL-SYNDROME; ADULT-TYPE HYPOLACTASIA; COWS MILK ALLERGY; CELIAC-DISEASE; LACTASE DEFICIENCY; INDUCED DIARRHEA; CROHNS-DISEASE; INTOLERANCE; MALABSORPTION; FERMENTATION;
D O I
10.1111/j.1365-2036.2008.03889.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Lactose intolerance affects 70% of the world population and may result in abdominal and systemic symptoms. Treatment focuses predominantly on the dietary restriction of food products containing lactose. Lactose is the most common form of excipient used in drug formulations and may be overlooked when advising these patients. To identify and quantify the amount of lactose in medications used for the treatment of gastrointestinal disorders and to identify 'lactose-free' preparations. Medications used for the treatment of gastrointestinal disorders were identified from the British National Formulary (BNF). Their formulation including excipients was obtained from the Medicines Compendium. The lactose content and quantity in selected medications was measured using high-performance liquid chromatography (HPLC). A wide range of medications prescribed for the treatment of gastrointestinal conditions contain lactose. We have quantified the lactose content in a selection of medications using HPLC. Lactose is present in amounts that may contribute towards symptoms. Lactose-free alternatives were also identified. Lactose is present in a range of medications and may contribute towards symptoms. This may not be recognized by the prescribing doctor as excipients are not listed in the BNF, and the quantity of lactose is not listed on the label or in the accompanying manufacturer's leaflet.
引用
收藏
页码:677 / 687
页数:11
相关论文
共 49 条
  • [1] Diet and irritable bowel syndrome
    Alpers, DH
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 2006, 22 (02) : 136 - 139
  • [2] DIAGNOSIS OF HYPOLACTASIA AND LACTOSE-MALABSORPTION
    AROLA, H
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 : 26 - 35
  • [3] Banos Madrid R, 2004, An Med Interna, V21, P212
  • [4] Berlin CM, 1997, PEDIATRICS, V99, P268
  • [5] BERNSTEIN CN, 1994, AM J GASTROENTEROL, V89, P872
  • [6] INCIDENCE AND CLINICAL-SIGNIFICANCE OF LACTOSE-MALABSORPTION IN ADULT CELIAC-DISEASE
    BODE, S
    GUDMANDHOYER, E
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1988, 23 (04) : 484 - 488
  • [7] Bohmer CJM, 1996, EUR J GASTROEN HEPAT, V8, P1013
  • [8] Excipients for direct compaction - an update
    Bolhuis, GK
    Armstrong, NA
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2006, 11 (01) : 111 - 124
  • [9] BRANDSTETTER RD, 1986, NEW ENGL J MED, V315, P1613
  • [10] The C/C-13910 and G/G-22018 genotypes for adult-type hypolactasia are not associated with inflammatory bowel disease
    Büning, C
    Ockenga, J
    Krüger, S
    Jurga, J
    Baier, P
    Dignass, A
    Vogel, A
    Strassburg, C
    Weltrich, R
    Genschel, J
    Lochs, H
    Schmidt, H
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (05) : 538 - 542